Azenta, Inc. (AZTA)
38.75
+4.27
(+12.38%)
USD |
NASDAQ |
Oct 02, 16:00
39.34
+0.59
(+1.52%)
After-Hours: 20:00
Azenta Cash from Operations (TTM) : 37.98M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 37.98M |
| March 31, 2026 | 62.34M |
| December 31, 2025 | 63.23M |
| September 30, 2025 | 72.18M |
| June 30, 2025 | 87.60M |
| March 31, 2025 | 71.57M |
| December 31, 2024 | 65.78M |
| September 30, 2024 | 49.74M |
| June 30, 2024 | 72.06M |
| March 31, 2024 | 79.03M |
| December 31, 2023 | 58.27M |
| September 30, 2023 | 17.49M |
| June 30, 2023 | -12.79M |
| March 31, 2023 | -449.48M |
| December 31, 2022 | -508.68M |
| September 30, 2022 | -466.05M |
| June 30, 2022 | -448.57M |
| March 31, 2022 | 16.18M |
| December 31, 2021 | 121.74M |
| September 30, 2021 | 149.86M |
| June 30, 2021 | 174.54M |
| March 31, 2021 | 155.86M |
| December 31, 2020 | 55.85M |
| September 30, 2020 | 37.87M |
| June 30, 2020 | 18.72M |
| Date | Value |
|---|---|
| March 31, 2020 | 28.61M |
| December 31, 2019 | 110.38M |
| September 30, 2019 | 90.90M |
| June 30, 2019 | 89.45M |
| March 31, 2019 | 72.77M |
| December 31, 2018 | 77.01M |
| September 30, 2018 | 73.96M |
| June 30, 2018 | 77.60M |
| March 31, 2018 | 76.35M |
| December 31, 2017 | 80.73M |
| September 30, 2017 | 96.22M |
| June 30, 2017 | 84.82M |
| March 31, 2017 | 82.47M |
| December 31, 2016 | 70.63M |
| September 30, 2016 | 39.55M |
| June 30, 2016 | 38.36M |
| March 31, 2016 | 39.14M |
| December 31, 2015 | 28.32M |
| September 30, 2015 | 43.73M |
| June 30, 2015 | 34.91M |
| March 31, 2015 | 23.08M |
| December 31, 2014 | 48.34M |
| September 30, 2014 | 53.78M |
| June 30, 2014 | 65.09M |
| March 31, 2014 | 73.30M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Lifecore Biomedical, Inc. | -- |
| Repligen Corp. | 134.86M |
| Bio-Techne Corp. | 292.07M |
| Codexis, Inc. | -10.40M |
| MetaStat, Inc. | -- |